1. "GME, Medicine"
  2. "Surgery"
  3. "Tow Center for Developmental Oncology (TCDO) "
Formats
  1. Journal Article (11)
  2. Meeting Abstract (5)
  3. Review (1)
Groups
  1. GME, Medicine (17)
  2. Graduate Medical Education (17)
  3. Surgery (17)
  4. Tow Center for Developmental Oncology (TCDO) (17)
  5. Department of Medicine (16)
  6. GSK Faculty (16)

More Groups

People
  1. Michael Berger (6)
  2. Britta Weigelt (5)
  3. Carol Aghajanian (5)
  4. Nadeem Abu-Rustum (5)
  5. Ying Liu (5)
  6. Ahmet Zehir (4)

More People

Years
  1. 2023 (6)
  2. 2022 (7)
  3. 2021 (1)
  4. 2020 (1)
  5. 2015 (1)
  6. 2013 (1)
Publications
  1. Nature Medicine (3)
  2. Cancer Discovery (2)
  3. Cancer Research (2)
  4. JCO Precision Oncology (2)
  5. Blood (1)
  6. Cancer Cell (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. Nature Publishing Group (4)
  3. American Society of Clinical Oncology (3)
  4. Cell Press (2)
  5. American Society of Hematology (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Germline pathogenic variants and genetic counseling by ancestry in patients with epithelial ovarian cancer
    Journal Article

    Sia, T. Y.; Maio, A.; Kemel, Y. M.; Arora, K. S.; Gordhandas, S. B.; Kahn, R. M.; Salo-Mullen, E. E.; Sheehan, M. A.; Tejada, P. R.; Bandlamudi, C.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Team approach: Extremity soft tissue sarcoma
    Review

    Morris, C. D.; Banks, L. B.; Fitzhugh, V. A.; McGill, K. C.; Deville, C.
    JBJS Reviews (2023)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab in advanced salivary gland cancer: A phase 2 trial
    Journal Article

    Vos, J. L.; Burman, B.; Jain, S.; Fitzgerald, C. W. R.; Sherman, E. J.; Dunn, L. A.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Ng, K. K.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade
    Journal Article

    Harrold, E. C.; Foote, M. B.; Rousseau, B.; Walch, H.; Kemel, Y.; Richards, A. L.; Keane, F.; Cercek, A.; Yaeger, R.; Rathkopf, D.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Long‐term follow-up of multicenter phase II trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in previously untreated patients with CLL/SLL
    Meeting Abstract

    Soumerai, J. D.; Dogan, A.; Seshan, V.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Abramson, J. S.; Hamilton, A. M.; Noy, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Comprehensive analysis of germline drivers in endometrial cancer
    Journal Article

    Gordhandas, S.; Rios-Doria, E.; Cadoo, K. A.; Catchings, A.; Maio, A.; Kemel, Y.; Sheehan, M.; Ranganathan, M.; Green, D.; Aryamvally, A.; more...
    JNCI: Journal of the National Cancer Institute (2023)

    Fulltext@MSK | Save
  • Prospective clinical genomic profiling of Ewing sarcoma: ERF and FGFR1 mutations as recurrent secondary alterations of potential biologic and therapeutic relevance
    Journal Article

    Ogura, K.; Elkrief, A.; Bowman, A. S.; Koche, R. P.; de Stanchina, E.; Benayed, R.; Mauguen, A.; Mattar, M. S.; Khodos, I.; Meyers, P. A.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Immune and malignant cell phenotypes of ovarian cancer are determined by distinct mutational processes
    Meeting Abstract

    Vázquez-García, I.; Uhlitz, F.; Ceglia, N.; Lim, J. L.; Wu, M.; Mohibullah, N.; Ruiz, A. E. B.; Boehm, K. M.; Bojilova, V.; Fong, C. J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Ovarian cancer mutational processes drive site-specific immune evasion
    Journal Article

    Vázquez-García, I.; Uhlitz, F.; Ceglia, N.; Lim, J. L. P.; Wu, M.; Mohibullah, N.; Niyazov, J.; Ruiz, A. E. B.; Boehm, K. M.; Bojilova, V.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Presence of immune infiltrates, increased expression of transposable elements, and viral response pathways in sarcoma associate with response to checkpoint inhibition
    Meeting Abstract

    Nacev, B. A.; Bradic, M.; Richards, A. L.; Kelly, C. M.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Chi, P.; Movva, S.; Thornton, K. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save